American CryoStem Corporation (CRYO) is a pioneering biotechnology brand founded in 2008. Operating in the fields of Regenerative and Personalized Medicine, they specialize in adipose tissue-derived stem cell technologies. Their goal is to heal and restore function to the human body.

With the support of their investors, American CryoStem drives innovation in the Bio-Technology industry and empowers individuals to live their best lives. The brand operates a cutting-edge, FDA-registered clinical laboratory in Monmouth Junction, New Jersey, as well as licensed laboratories in Hong Kong, China, and Tokyo, Japan. These facilities utilize proprietary technology for the collection, processing, bio-banking of adipose tissue (fat), and the culturing and differentiation of adipose-derived stem cells (ADSCs) for use in regenerative medicine.

American CryoStem's research and development efforts focus on the discovery, development, and commercialization of ADSCs. They also collaborate with synergistic partners to develop regenerative medicine applications and new intellectual property. As a leader in the industry, American CryoStem offers a comprehensive pipeline of safe and effective cellular medicine products and applications.

Their innovative platform technology allows for complete control of the stem cell processing and manufacturing chain. With a patient-centric approach, American CryoStem enables individuals to improve their quality of life by utilizing their cellular platform and multiple products for regenerative medicine needs at every stage of life. Their cutting-edge stem cell products participate in the three major categories of the regenerative and personalized medicine industry: cell therapy, tissue engineering, and diagnostics and lab services.

These applications have the potential to treat diseases and injuries such as arthritis, heart disease, diabetes, multiple sclerosis, Parkinson's disease, Alzheimer's disease, and orthopedic applications, among others. In summary, American CryoStem Corporation is a pioneering biotechnology brand that leverages adipose tissue-derived stem cell technologies for regenerative and personalized medicine. With innovative research and development, comprehensive cellular platforms, and a patient-focused approach, they are at the forefront of advancing healthcare and improving patient lives